{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:38:41Z","timestamp":1761597521652},"reference-count":24,"publisher":"Societas Neurologica Japonica","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5692\/clinicalneurol.54.417","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T02:20:16Z","timestamp":1402971616000},"page":"417-422","source":"Crossref","is-referenced-by-count":5,"title":["Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation"],"prefix":"10.5692","volume":"54","author":[{"given":"Masako","family":"Mukai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imaharu","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zeviani M, Antozzi C. Mitochondrial disorders. Mol Hum Reprod 1997;3:133-148.","DOI":"10.1093\/molehr\/3.2.133"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chinnery PF, Schon EA. Mitochondria. J Neurol Neurosurg Psychiatry 2003;74:1188-1199.","DOI":"10.1136\/jnnp.74.9.1188"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hudson G, Chinnery PF. Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet 2006;15:R244-252.","DOI":"10.1093\/hmg\/ddl233"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sato K, Yabe I, Yaguchi H, et al. Genetic analysis of two Japanese families with progressive external ophthalmoplegia and parkinsonism. J Neurol 2011;258:1327-1332.","DOI":"10.1007\/s00415-011-5936-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mukai M, Sugaya K, Yabe I, et al. Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in POLG1. Parkinsonism Relat Disord 2013;19:821-824.","DOI":"10.1016\/j.parkreldis.2013.04.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations:clinical and molecular genetic study. Lancet 2004;364:875-882.","DOI":"10.1016\/S0140-6736(04)16983-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Synofzik M, Asmus F, Reimold M, et al. Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism. Mov Disord 2010;25:243-245.","DOI":"10.1002\/mds.22865"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pagnamenta AT, Taanman JW, Wilson CJ, et al. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 2006;21:2467-2473.","DOI":"10.1093\/humrep\/del076"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002;52:211-219.","DOI":"10.1002\/ana.10278"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Servidei S, Zeviani M, Manfredi G, et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA clinical, morphologic, and biochemical studies. Neurology 1991;41:1053-1059.","DOI":"10.1212\/WNL.41.7.1053"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Moslemi AR, Melberg A, Holme E, et al. Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol 1996;40:707-713.","DOI":"10.1002\/ana.410400506"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kollberg G, Jansson M, P\u00e9rez-Bercoff A, et al. Low frequency of mtDNA point mutations in patients with PEO associated with POLG1 mutations. Eur J Hum Genet 2005;13:463-469.","DOI":"10.1038\/sj.ejhg.5201341"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006;129:1674-1684.","DOI":"10.1093\/brain\/awl088"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Gonz\u00e1lez-Vioque E, Bl\u00e1zquez A, Fern\u00e1ndez-Moreira D, et al. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a spanish population. Arch Neurol 2006;63:107-111.","DOI":"10.1001\/archneur.63.1.107"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006;129:1685-1692.","DOI":"10.1093\/brain\/awl097"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Milone M, Brunetti-Pierri N, Tang LY, et al. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutation. Neuromuscul Disord 2008;18:626-632.","DOI":"10.1016\/j.nmd.2008.05.009"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Neeve VC, Samuels DC, Bindoff LA, et al. What is influencing the phenotype of the common homozygous polymerase-\u03b3 mutation p.Ala467Thr? Brain 2012;135:3614-3626.","DOI":"10.1093\/brain\/aws298"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Naviaux RK, Nguyen KV. POLG mutations associated with Alpers\u2019 syndrome and mitochondrial DNA depletion. Ann Neurol 2004;55:706-712.","DOI":"10.1002\/ana.20079"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nguyen KV, \u00d8stergaard E, Ravn SH, et al. POLG mutations in Alpers syndrome. Neurology 2005;65:1493-1495.","DOI":"10.1212\/01.wnl.0000182814.55361.70"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Van Goethem G, Martin JJ, Dermaut B, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003;13:133-142.","DOI":"10.1016\/S0960-8966(02)00216-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-727.","DOI":"10.1212\/WNL.44.4.721"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Carelli V, Giordano C, d\u2019Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet 2003;19:257-262.","DOI":"10.1016\/S0168-9525(03)00072-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Van Goethem G, Luoma P, Rantam\u00e4ki M, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004;63:1251\u20131257.","DOI":"10.1212\/01.WNL.0000140494.58732.83"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lax NZ, Whittaker RG, Hepplewhite PD, et al. Sensory neuronopathy in patients harbouring recessive polymerase g mutations. Brain 2012;135:62-71.","DOI":"10.1093\/brain\/awr326"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c7\u5019\u7fa4\u3068\u591a\u767a\u30cb\u30e5\u30fc\u30ed\u30d1\u30c1\u30fc\u3092\u5448\u3057\uff0c&lt;i&gt;POLG1&lt;\/i&gt;\u907a\u4f1d\u5b50\u5909\u7570\u3092\u307f\u3068\u3081\u305f\u5bb6\u65cf\u6027\u9032\u884c\u6027\u5916\u773c\u7b4b\u9ebb\u75fa\u306e1\u5bb6\u7cfb"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T14:59:30Z","timestamp":1498143570000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/54.417?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.54.417","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}